GENE ONLINE|News &
Mount Sinai Study Reveals Novel Immunotherapy Strategy to Improve Colorectal Cancer Treatment Outcomes
A new study from the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center reveals a potential strategy to overcome resistance to immunotherapy in colorectal cancer treatment. The research introduces a novel immunotherapeutic approach designed to enhance the effectiveness of current cancer treatments.
The study details how researchers are working to create a more effective treatment by facilitating communication between immune cells and cancer cells. Scientists are exploring methods to manipulate the tumor microenvironment to make it more susceptible to immune attack. The researchers believe this approach could significantly improve outcomes for patients with colorectal cancer who do not respond to existing therapies.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: May 6, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
Digitalis Glycosides Studied for Heart Failure Treatment at ESC Heart Failure 2026 Congress
2026-05-10
Digoxin Lowers Death Risk and Heart Failure in Rheumatic Heart Disease Patients, Study Finds
2026-05-10
New Test Detects Biomarkers for Frontotemporal Lobar Degeneration, a Rare Dementia Affecting Over 57 Million Globally
2026-05-10
